Clinical Trial Update: Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) Trial [Phase 2, Phase 3]

View source ↗

Summary

The Melatonin In Reduction of Chemotherapy-Induced Toxicity (MIRCIT) trial, a Phase 2/3 study sponsored by Khon Kaen University, has completed and evaluates mel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Khon Kaen University | Conditions: Advanced Stage Cancer | Phase 2, Phase 3 | Status: COMPLETED